Mizoguchi J, Morohoshi T, Suginaka H
J Antibiot (Tokyo). 1980 Jul;33(7):731-6. doi: 10.7164/antibiotics.33.731.
The membrane fraction prepared from beta-lactamase producing Citrobacter freundii GN346 catalyzed in vitro peptidoglycan synthesis from uridine-5'-diphosphate-N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelyl- D-alanyl-D-alanine and uridine-5'-diphosphate-N-acetylglucosamine, which was accompanied by the release of alanine from the carboxyl terminal end of the former substrate. Though this reaction was inhibited by benzylpenicillin (PCG) and ampicillin (ABPC), the reaction was relatively insensitive compared with that catalyzed by the membrane fraction from a derived beta-lactamaseless mutant strain GN346/16. In contrast, the enzyme activity of the parent strain was strongly inhibited by a combination of PCG or ABPC and dicloxacillin (MDIPC). The beta-lactamase present in the membrane fraction from the parent strain showed stronger activity than that from the mutant strain, and the activity was inhibited by MDIPC as in the case of the soluble enzyme localized in the periplasmic space.
从产β-内酰胺酶的弗氏柠檬酸杆菌GN346制备的膜组分催化了由尿苷-5'-二磷酸-N-乙酰胞壁酰-L-丙氨酰-D-谷氨酰-内消旋二氨基庚二酸-D-丙氨酰-D-丙氨酸和尿苷-5'-二磷酸-N-乙酰葡糖胺进行的体外肽聚糖合成,此过程伴随着前一种底物羧基末端丙氨酸的释放。尽管该反应受到苄青霉素(PCG)和氨苄青霉素(ABPC)的抑制,但与源自无β-内酰胺酶突变株GN346/16的膜组分所催化的反应相比,该反应相对不敏感。相反,亲本菌株的酶活性受到PCG或ABPC与双氯西林(MDIPC)组合的强烈抑制。亲本菌株膜组分中存在的β-内酰胺酶比突变株的表现出更强的活性,并且该活性如位于周质空间中的可溶性酶的情况一样受到MDIPC的抑制。